Evidence map›Paper›PMID 26501102›Full record

ArticleEBioMedicine2015

Muscleblind-Like 1 and Muscleblind-Like 3 Depletion Synergistically Enhances Myotonia by Altering Clc-1 RNA Translation.

Jongkyu Choi, Kirkwood E Personius, Marino DiFranco, Warunee Dansithong, Carl Yu, Saumya Srivastava, Donald M Dixon, Darshan B Bhatt, Lucio Comai, Julio L Vergara and 1 more

Open access · goldAbstract read
In one paragraph

Article in EBioMedicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.0field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Frontiers in neurology · 2018
    Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Jongkyu ChoiDepartment of Biochemistry and Molecular Biology, University of Southern California, Los Angeles, CA 90033, USA.
Kirkwood E PersoniusDepartment of Rehabilitation Science and Program in Neuroscience, School of Public Health and Health Professions, University at Buffalo, Buffalo, NY 14214, USA.
Marino DiFrancoDepartment of Physiology, David Geffen School of Medicine, UCLA, Los Angeles, CA 90095, USA.
Warunee DansithongDepartment of Biochemistry and Molecular Biology, University of Southern California, Los Angeles, CA 90033, USA.
Carl YuDepartment of Physiology, David Geffen School of Medicine, UCLA, Los Angeles, CA 90095, USA.
Saumya SrivastavaDepartment of Biochemistry and Molecular Biology, University of Southern California, Los Angeles, CA 90033, USA.
Donald M DixonDepartment of Biochemistry and Molecular Biology, University of Southern California, Los Angeles, CA 90033, USA.
Darshan B BhattDepartment of Rehabilitation Science and Program in Neuroscience, School of Public Health and Health Professions, University at Buffalo, Buffalo, NY 14214, USA.
Lucio ComaiDepartment of Microbiology and Immunology, University of Southern California, Los Angeles, CA 90033, USA.
Julio L VergaraDepartment of Physiology, David Geffen School of Medicine, UCLA, Los Angeles, CA 90095, USA.
Sita ReddyDepartment of Biochemistry and Molecular Biology, University of Southern California, Los Angeles, CA 90033, USA.
University of Southern California · USUniversity of California, Los Angeles · USUniversity at Buffalo, State University of New York · US

Funding

MODULATION OF SARCOPLASMIC RETICULUM CALCIUM RELEASER01AR041802 · NIAMS · BAYLOR COLLEGE OF MEDICINE · PI HAMILTON, SUSAN L, INGALLS, CHRISTOPHER · 1993 to 2014
$5.6M
Excitation-Contraction Coupling in Normal and Dystrophic Mammalian MuscleR01AR047664 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI VERGARA, JULIO L · 2003 to 2013
$2.7M
Biochemical analyses of muscleblind complexes in myotonic dystrophyR01NS060839 · NINDS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI COMAI, LUCIO, REDDY, SITA · 2008 to 2012
$2.6M
Mechanism of Small Molecule Mediated Rescue of Mytonic DystrophyR01NS080547 · NINDS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI REDDY, SITA · 2013 to 2017
$2.2M
Role of the Transverse Tubular System in Mammalian Skeletal Muscle ExcitabilityR01AR054816 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI VERGARA, JULIO L · 2007 to 2011
$1.6M
Excitation-contraction Coupling in Normal and Dystrophic Mammalian MuscleR56AR047664 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI VERGARA, JULIO L · 2008 to 2008
$339k
NIAMS NIH HHS AR041802NIAMS NIH HHS AR047664NIAMS NIH HHS AR54816NIAMS NIH HHS R01 AR041802NIAMS NIH HHS R01 AR047664NIAMS NIH HHS R01 AR054816NIAMS NIH HHS R56 AR047664NINDS NIH HHS R01 NS060839NINDS NIH HHS R01 NS080547
6 · The paper itself

Abstract

Loss of Muscleblind-like 1 (Mbnl1) is known to alter Clc-1 splicing to result in myotonia. Mbnl1(ΔE3/ΔE3)/Mbnl3(ΔE2) mice, depleted of Mbnl1 and Mbnl3, demonstrate a profound enhancement of myotonia and an increase in the number of muscle fibers with very low Clc-1 currents, where gClmax values approach ~ 1 mS/cm(2), with the absence of a further enhancement in Clc-1 splice errors, alterations in polyA site selection or Clc-1 localization. Significantly, Mbnl1(ΔE3/ΔE3)/Mbnl3(ΔE2) muscles demonstrate an aberrant accumulation of Clc-1 RNA on monosomes and on the first polysomes. Mbnl1 and Mbnl3 bind Clc-1 RNA and both proteins bind Hsp70 and eEF1A, with these associations being reduced in the presence of RNA. Thus binding of Mbnl1 and Mbnl3 to Clc-1 mRNA engaged with ribosomes can facilitate an increase in the local concentration of Hsp70 and eEF1A to assist Clc-1 translation. Dual depletion of Mbnl1 and Mbnl3 therefore initiates both Clc-1 splice errors and translation defects to synergistically enhance myotonia. As the HSA(LR) model for myotonic dystrophy (DM1) shows similar Clc-1 defects, this study demonstrates that both splice errors and translation defects are required for DM1 pathology to manifest. RESEARCH IN CONTEXT: Research in context: Myotonic Dystrophy type 1 (DM1) is a dominant disorder resulting from the expression of expanded CUG repeat RNA, which aberrantly sequesters and inactivates the muscleblind-like (MBNL) family of proteins. In mice, inactivation of Mbnl1 is known to alter Clc-1 splicing to result in myotonia. We demonstrate that concurrent depletion of Mbnl1 and Mbnl3 results in a synergistic enhancement of myotonia, with an increase in muscle fibers showing low chloride currents. The observed synergism results from the aberrant accumulation of Clc-1 mRNA on monosomes and the first polysomes. This translation error reflects the ability of Mbnl1 and Mbnl3 to act as adaptors that recruit Hsp70 and eEF1A to the Clc-1 mRNA engaged with ribosomes, to facilitate translation. Thus our study demonstrates that Clc-1 RNA translation defects work coordinately with Clc-1 splice errors to synergistically enhance myotonia in mice lacking Mbnl1 and Mbnl3.

Indexed as

Alternative SplicingAnimalsCarrier ProteinsCell LineChloride ChannelsDNA-Binding ProteinsHEK293 CellsHSP70 Heat-Shock ProteinsHumansImmunoblottingMice, 129 StrainMice, Inbred C57BLMice, KnockoutMuscle, SkeletalMyotoniaMyotonic DystrophyCarrier ProteinsChloride ChannelsCLC-1 channelDNA-Binding ProteinsHSP70 Heat-Shock ProteinsMbnl1 protein, mouseMBNL3 protein, mousePeptide Elongation Factor 1RNA-Binding ProteinsRNA, MessengerClc-1Muscleblind-like 1Muscleblind-like 2MyotoniaRNA translation

Identifiers

PMID26501102
PMCPMC4588380
OpenAlexW1844994038

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.